Merck KGaA
XETRA:MRK
Merck KGaA
Revenue
Merck KGaA
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Merck KGaA
XETRA:MRK
|
Revenue
€21B
|
CAGR 3-Years
6%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Revenue
$314k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bayer AG
XETRA:BAYN
|
Revenue
€47.6B
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
2%
|
|
MPH Health Care AG
XETRA:93M1
|
Revenue
€37.4k
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
N/A
|
|
Dermapharm Holding SE
XETRA:DMP
|
Revenue
€1.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Revenue
€85.8m
|
CAGR 3-Years
11%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
See Also
What is Merck KGaA's Revenue?
Revenue
21B
EUR
Based on the financial report for Dec 31, 2023, Merck KGaA's Revenue amounts to 21B EUR.
What is Merck KGaA's Revenue growth rate?
Revenue CAGR 10Y
7%
Over the last year, the Revenue growth was -6%. The average annual Revenue growth rates for Merck KGaA have been 6% over the past three years , 7% over the past five years , and 7% over the past ten years .